Integra Lifesciences Holdings (IART) Change in Acquisitions & Divestments (2012 - 2025)
Integra Lifesciences Holdings (IART) reported Change in Acquisitions & Divestments of $7.0 million for Q4 2025, down 80.14% on a YoY basis from $35.3 million in Q4 2024, and down 80.14% sequentially from $35.2 million in Q4 2024.
Integra Lifesciences Holdings (IART) Change in Acquisitions & Divestments (2012 - 2025) Analysis & Trends
Integra Lifesciences Holdings (IART) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $7.0 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 80.14% year-over-year to $7.0 million; the trailing twelve-month figure through Dec 2025 stood at $37.3 million (up 23.07% YoY), and the FY2025 full-year result was $7.0 million, down 87.16% from the prior year.
- Change in Acquisitions & Divestments declined to $7.0 million in Q4 2025, from $35.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $35.2 million in Q4 2024 to a low of -$4.9 million in Q4 2022.
- A 4-year average of $7.5 million and a median of $76000.0 in 2021 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments sank 6359.21% in 2022 and tumbled 80.14% in 2025, its largest moves.
- Tracing IART's Change in Acquisitions & Divestments over 4 years: stood at -$76000.0 in 2021, then tumbled by 6359.21% to -$4.9 million in 2022, then jumped by 818.07% to $35.2 million in 2024, then plunged by 80.14% to $7.0 million in 2025.
- Business Quant data shows IART's Change in Acquisitions & Divestments at $7.0 million in Q4 2025, $35.2 million in Q4 2024, and -$4.9 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.24 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 35.25 Mn |
| Dec 31, 2024 | 35.25 Mn |
| Dec 31, 2022 | -4.91 Mn |
| Dec 31, 2022 | -4.91 Mn |
| Dec 31, 2021 | -76,000.00 |
| Dec 31, 2021 | -76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2019 | 257,000.00 |
| Sep 30, 2019 | 257,000.00 |
| Jun 30, 2019 | 250,000.00 |
| Jun 30, 2019 | 250,000.00 |
| Mar 31, 2019 | 245,000.00 |
| Mar 31, 2019 | 245,000.00 |
| Dec 31, 2018 | 231,000.00 |
| Dec 31, 2018 | 231,000.00 |
| Sep 30, 2018 | 233,000.00 |
| Sep 30, 2018 | 233,000.00 |